Bryan Johnson Founder: Early Life and Career
Bryan Johnson was born in 1977 in Provo, Utah. He started his career as a motorcycle salesman before founding OS Fund in 2014, a venture capital firm investing in hard science and technology companies. He later co-founded Braintree, a payment processing company that was acquired by PayPal for $800 million in 2013, a deal often cited as a major milestone in his career Forbes.
After the Braintree sale, Johnson used a significant portion of the proceeds to launch OS Fund, which focuses on early-stage companies in fields like synthetic biology, artificial intelligence, and quantum computing. The fund has backed companies such as SpaceX and Tesla, aligning with Johnson's focus on transformative technologies SEC.
Bryan Johnson Founder: Companies and Investments
Bryan Johnson is the founder and CEO of Blueprint, a longevity-focused company that aims to reverse biological aging through a strict regimen of diet, exercise, and medical interventions. Blueprint offers a program that includes regular blood testing, supplements, and a vegan diet, with Johnson publicly sharing his own biological age data Forbes.
Johnson also founded Kernel, a neuroscience company developing advanced brain imaging technology to understand and enhance human cognition. Kernel's devices are designed to measure and record brain activity with high resolution, aiming to create applications for mental health and cognitive enhancement. The company represents Johnson's push into the intersection of biology and technology Kernel.
Bryan Johnson Founder: The Longevity Protocol and Public Profile
Bryan Johnson's daily routine, often called the "Blueprint" protocol, has become a central part of his public identity. The protocol involves a strict vegan diet, 100 ounces of green juice daily, and a rigorous exercise regimen. Johnson tracks over 100 biomarkers daily and has published data showing significant reductions in his biological age markers Healthline.
Johnson's approach to longevity has drawn both attention and skepticism from the medical community. He has publicly shared his blood work and aging metrics, claiming to have reduced his biological age by several years. His transparency has made him a prominent figure in the biohacking and life extension communities, with his story frequently covered in major media outlets MIT Technology Review.